Concepedia

Ronald Lieberman

RL

42

Publications

1.5K

Citations

24

H-Index

1974

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

The University of Texas MD Anderson Cancer Center

University of Pittsburgh

University of California, San Francisco

Ronald Lieberman is an author at National Cancer Institute specializing in medicine, oncology, and pharmacology.

Top concepts

Publications per year

1974–2014

42

Publications

42

Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.

Chris H. Takimoto, Kira Glover-Cutter, Xiaoke Huang et al. · PubMed · 2003 · 129 citations

, , +11

ANTIANDROGEN, VACCINE AND COMBINATION THERAPY IN PATIENTS WITH NONMETASTATIC HORMONE REFRACTORY PROSTATE CANCER

Philip M. Arlen, James L. Gulley, N. Todd et al. · The Journal of Urology · 2005 · 109 citations · Full text

The Effect of Difluoromethylornithine on Decreasing Prostate Size and Polyamines in Men: Results of a Year-Long Phase IIb Randomized Placebo-Controlled Chemoprevention Trial

Anne R. Simoneau, Eugene W. Gerner, Ray B. Nagle et al. · Cancer Epidemiology Biomarkers & Prevention · 2008 · 95 citations · Full text

Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients.

William L. Dahut, Nancy Harold, Chris H. Takimoto et al. · Journal of Clinical Oncology · 1996 · 71 citations

Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer

Gary J. Kelloff, Ronald Lieberman, Vernon E. Steele et al. · Urology · 2001 · 66 citations

, , +6

Rows per page

1–5 of 42